Evidence map›Paper›PMID 15331711›Full record

ArticleJournal of virology2004

Long-term persistence of infection in chimpanzees inoculated with an infectious hepatitis C virus clone is associated with a decrease in the viral amino acid substitution rate and low levels of heterogeneity.

Javier Fernandez, Deborah Taylor, Duncan R Morhardt, Kathleen Mihalik, Montserrat Puig, Charles M Rice, Stephen M Feinstone, Marian E Major

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Marmosets as models of infectious diseases.Frontiers in cellular and infection microbiology · 2024
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Adaptive immunity to the hepatitis C virus.Advances in virus research · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Javier FernandezLaboratory of Hepatitis Viruses, Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Building 29A, Room 1D10, HVM 448, 8800 Rockville Pike, Bethesda, MD 20892, USA.
Deborah Taylor
Duncan R Morhardt
Kathleen Mihalik
Montserrat Puig
Charles M Rice
Stephen M Feinstone
Marian E Major
Center for Biologics Evaluation and Research · USRockefeller University · US

Funding

IMMUNOTHERAPY PROTECTION &VACCINES FOR HEPATITIS CR01CA085883 · NCI · WASHINGTON UNIVERSITY · PI RICE, CHARLES M. · 1999 to 2003
$1.4M
NCI NIH HHS CA85883NCI NIH HHS R01 CA085883
6 · The paper itself

Abstract

Two chimpanzees, 1535 and 1536, became persistently infected following inoculation with RNA transcripts from cDNA clones of hepatitis C virus (HCV). Analysis of the HCV genomes from both animals showed an accumulation of amino acid substitutions over time. The appearance of substitutions in the envelope genes was associated with increased antienvelope antibody titers. However, extensive mutations were not incorporated into hypervariable region 1 (HVR1). A comparison of the nonsynonymous substitution rate/synonymous substitution rate was made at various time points to analyze selective pressure. The highest level of selective pressure occurred during the acute phase and decreased as the infection continued. The nonsynonymous substitution rate was initially higher than the synonymous substitution rate but decreased over time from 3.3 x 10(-3) (chimpanzee 1535) and 3.2 x 10(-3) (chimpanzee 1536) substitutions/site/year at week 26 to 1.4 x 10(-3) (chimpanzee 1535) and 1.7 x 10(-3) (chimpanzee 1536) at week 216, while the synonymous substitution rate remained steady at approximately 1 x 10(-3) substitutions/site/year. Analysis of PCR products using single-stranded conformational polymorphism indicated a low level of heterogeneity in the viral genome. The results of these studies confirm that the persistence of infection is not solely due to changes in HVR1 or heterogeneity and that the majority of variants observed in natural infections could not arise simply through mutation during the time period most humans and chimpanzees are observed. These data also indicate that immune pressure and selection continue throughout the chronic phase.

Indexed as

Pan troglodytesAmino Acid SubstitutionAnimalsApe DiseasesGenome, ViralHepacivirusHepatitis C, ChronicHumansPolymorphism, Single-Stranded ConformationalSelection, GeneticViral Envelope ProteinsViral ProteinsE1 protein, Hepatitis C virusglycoprotein E2, Hepatitis C virusHVR1 protein, Hepatitis C virusViral Envelope ProteinsViral Proteins

Identifiers

PMID15331711
PMCPMC514970
OpenAlexW2137332228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.